In Vitro Study of Picloxidine 0.05 % Antiviral Activity (on the Example of Adenovirus)
https://doi.org/10.18008/1816-5095-2020-3S-634-639
Abstract
Introduction. Lack of antiviral drug forms in ophthalmology stimulates to study the efficacy of drugs of other pharmacological groups with potential antiviral activity. Adenoviral eye infections are widespread and highly contagious.
Material and methods. The antiviral effect of the drug was estimated by changing the DNA titer of the virus in adenovirus-infected cells, controlling. the specificity of the viral affection by setting PCR in real time. The cytotoxic effect of Vitabact® was studied on Vero cell culture.
Results. Installations of the preparation according to the treatment scheme (after infection of the culture) resulted in 2.7-fold decrease in the viral DNA amount. When Vitabact® was injected into cells in dilution of 1/128 (the first dilution of the drug that does not refuse the cytotoxic effect on Vero cells) according to the prophylactic scheme the level of adenovirus replication decreased by 1.7 times.
Conclusions. The preparation of pycloxidine had the maximum antiviral effect in the treatment scheme mode. This circumstance opens the perspective of specifying the spectrum and mechanisms of antiviral effect of pixloxidine and makes it possible to use Vitabakt as a component of the second stage (starting from 10–12 day of the disease) of empirical therapy of viral conjunctivitis.
About the Authors
G. M. ChernakovaRussian Federation
PhD, associate professor
Beskudnikovsky blvd, 59А, Moscow, 127486, Russian Federation
D. Yu. Maychuk
Russian Federation
MD, head of therapy department
Beskudnikovsky blvd, 59А, Moscow, 127486, Russian Federation
E. A. Klescheva
Russian Federation
PhD, assistant
Barrikadnaya str., 2/1, Moscow, 125993, Russian Federation
M. V. Mezentseva
Russian Federation
Dr. of Biological Sciences, head of the laboratory
Gamalei str., 18, Moscow, 123098, Russian Federation
L. I. Russu
Russian Federation
researcher
Gamalei str., 18, Moscow, 123098, Russian Federation
I. A. Suetina
Russian Federation
Candidate of Biological Sciences, leading researcher
Gamalei str., 18, Moscow, 123098, Russian Federation
E. I. Isaeva
Russian Federation
Candidate of Biological Sciences, head of the immunology laboratory
Gamalei str., 18, Moscow, 123098, Russian Federation
References
1. Okolov I.N. Monitoring the antimicrobial activity of antiseptic eye drops. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2019;12(3):67–74 (In Russ.). DOI: 10.17816/OV16300
2. Pirogov Y.I., Shustrova T.A., Oblovatskaya E.S., Khromova E.S. The state of conjunctival flora and its susceptibility to “Vitabakt” in cataract patients compared to other antibiotics used in ophthalmologic practice. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2018;11(2):75–79 (In Russ.). DOI: 10.17816/OV11275‑79
3. Kochergin S.A., Chernakova G.M., Kleshcheva E.A., Shapoval I.M., Mezentseva M.V. Local cytokine state by adenoviral eye infection. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2011;4(4):32–40 (In Russ.).
4. Kochergin S.A., Chernakova G.M., Kleshcheva E.A., Semenova T.B. Modern approaches to the treatment of viral and nonviral conjunctivitis. Russian ophthalmological journal = Rossiyskiy oftal’mologicheskiy zhurnal. 2014;7(4):32–39 (In Russ.).
5. Maychuk D.Yu., Vasil’eva O.A., Russu L.I., Mezentseva M.V. Clinical and immunological comparisons of therapeutic regimens for corneal infiltrates secondary to adenoviral keratoconjunctivitis. Annals of Ophthalmology = Vestnik oftal’mologii 2015;131(4):49–55 (In Russ.). DOI: 10.17116/oftalma2015131449‑55
6. Maychuk D.Yu., Vasil’eva O.A. Use of cyclosporine 0.05 % in various ocular surface disorders. Fyodorov Journal of Ophthalmic Surgery = Oftal’mokhirurgiya 2014;2:66–72 (In Russ.).
7. L’vov D.K., Shchelkanov M.Yu. Adenoviruses (Adenoviridae). Medical virology. Moscow: Medical news agency; 2008:245–250 (In Russ.).
8. Kirichenko I.M., Barinskii I.F., Alimbarova L.M. In vitro study of Miramistine® antiviral properties with respect to herpes simplex virus types 1 and 2. Polyclinic = Poliklinika. 2011;3:98–99 (In Russ.).
9. Poryvaeva A.P., Mal’chikov I.A., Shmeleva N.A., Bakharev A.A. Effect of miramistin® on infection caused by herpes simplex virus in vitro. Journal of Ural Medical Academic Science = Vestnik Ural’skoi meditsinskoi akademicheskoi nauki. 2012;3(40):37–39 (In Russ.).
10. Kirin V.P., Smolentsev A.I., Maksakov V.A., Demkin A.G., Il’icheva T.N. COBALT(III) complexes with biguanide derivatives: synthesis, structures, and antiviral activity. Russian Journal of Coordination Chemistry = Koordinacionnaja himija. 2016;42(4):230–236 (In Russ.). DOI: 10.7868/S0132344X16040022
11. Maichuk Yu.F. Ophthalmoferon. Experience in expanding the field of application for eye diseases. Мoscow, 2012. 125 p. (In Russ.).
12. Chernakova G.M., Maychuk D.Yu., Murtazalieva S.M., Slonimsky Yu.B., Kleshcheva E.A., Yatsyshina S.B., Ageeva M.R. Еpidemiological, Etiological and Clinical Aspects of Acute Infectious Conjunctives — at the Crossroads of Ophthalmology and Epidemiology (Clinical and Laboratory Study). Оphthalmology in Russia=Oftal’mologiya. 2018;15(4):476–483 (In Russ.). DOI: 10.18008/1816‑5095‑2018‑4‑476‑483
Review
For citations:
Chernakova G.M., Maychuk D.Yu., Klescheva E.A., Mezentseva M.V., Russu L.I., Suetina I.A., Isaeva E.I. In Vitro Study of Picloxidine 0.05 % Antiviral Activity (on the Example of Adenovirus). Ophthalmology in Russia. 2020;17(3s):634-639. (In Russ.) https://doi.org/10.18008/1816-5095-2020-3S-634-639